The portfolio combines rapid lateral-flow assays, AI-powered interpretation and mobile-integrated tools for early disease detection.
Designed for faster clinical workflows and point-of-care decision-making.
Data-driven approaches intended to improve interpretation and reduce uncertainty.
Simple workflows designed to minimize discomfort and complexity.
Multiple disease markers can be assessed within one testing approach.
Digital access for data tracking, consultation and connected workflows.
Designed with broader screening programs and healthcare networks in mind.
Multiplex test concept